Target intelligence / Profile preview

MicroRNA-1976 target mRNAs (miR-1976 targets)

Target
miR-1976 targets
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

MicroRNA-1976 (miR-1976) target mRNAs represent a diverse set of messenger RNAs that contain sequences complementary to the seed region of miR-1976, typically located in their 3' untranslated regions (UTRs). miR-1976 is a small non-coding RNA that acts as a post-transcriptional regulator, primarily functioning as a tumor suppressor in various malignancies, including lung, breast, and colorectal cancers (1.2.1, 1.2.2). By binding to its target mRNAs, such as NCAPH, PLCE1, and XAF1, miR-1976 induces mRNA degradation or translational repression, thereby modulating critical cellular processes like proliferation, apoptosis, and metastasis (1.2.1, 2.1.4). In cancer, miR-1976 is frequently downregulated, leading to the overexpression of its oncogenic targets and the activation of pro-survival pathways like NF-κB (1.2.1, 1.2.3). Conversely, in certain cardiovascular conditions like sick sinus syndrome, miR-1976 may be upregulated, targeting calcium channels and contributing to sinoatrial node degeneration (2.1.5). Therapeutic strategies involving miR-1976 mimics aim to restore its tumor-suppressive function by silencing its oncogenic target mRNAs, while miR-1976 inhibitors are explored for conditions where the miRNA is pathologically overexpressed (1.1.2, 2.1.3).

Other names
Endogenous miR-1976 seed-matched mRNAsmiR-1976 regulated geneshsa-miR-1976 targetsmiR-1976 targetome
02

Mechanism of action

Binding of miR-1976 to the 3' UTR of target mRNAs via seed-sequence complementarity, leading to mRNA degradation or translational inhibition.

03

Biological functions

Post-transcriptional gene regulationCell proliferationApoptosisCell migrationEpithelial-mesenchymal transitionNF-kappaB signaling regulation
04

Disease associations

CancerLung adenocarcinomaNon-small cell lung cancerBreast cancerColorectal cancerHepatocellular carcinomaPancreatic cancerSick sinus syndrome
05

Safety considerations

Off-target effects on non-disease-related mRNAsSystemic toxicity of RNA delivery vehiclesPotential for immune activation by synthetic RNAs
06

Interacting drugs

miR-1976 mimic

3 more in the full profile.

07

Biomarkers

miR-1976 expression levelNCAPH expressionPLCE1 expressionXAF1 expression

Beyond the preview

Go deeper on MicroRNA-1976 target mRNAs (miR-1976 targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-1976 target mRNAs (miR-1976 targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call